Cargando…
Antileishmanial activity of MDL 28170, a potent calpain inhibitor
Several calpain inhibitors are under development and some are useful agents against important human pathogens. We therefore investigated the effect of MDL 28170, a potent calpain inhibitor, on the growth of Leishmania amazonensis. After 48 h of treatment, the inhibitor exhibited a dose-dependent ant...
Autores principales: | d’Avila-Levy, Claudia M., Marinho, Fernanda A., Santos, Lívia O., Martins, Juliana L., Santos, André L.S., Branquinha, Marta H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V. and the International Society of Chemotherapy.
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126437/ https://www.ncbi.nlm.nih.gov/pubmed/16842979 http://dx.doi.org/10.1016/j.ijantimicag.2006.03.021 |
Ejemplares similares
-
Antileishmanial Efficacy of the Calpain Inhibitor MDL28170 in Combination with Amphotericin B
por: Branquinha, Marta H., et al.
Publicado: (2022) -
The Calpain Inhibitor MDL28170 Induces the Expression of Apoptotic Markers in Leishmania amazonensis Promastigotes
por: Marinho, Fernanda A., et al.
Publicado: (2014) -
MDL28170, a Calpain Inhibitor, Affects Trypanosoma cruzi Metacyclogenesis, Ultrastructure and Attachment to Rhodnius prolixus Midgut
por: Ennes-Vidal, Vítor, et al.
Publicado: (2011) -
Calpain inhibitor MDL28170 alleviates cerebral ischemia‑reperfusion injury by suppressing inflammation and autophagy in a rat model of cardiac arrest
por: Wang, Wen-Yan, et al.
Publicado: (2023) -
MDL-28170 Has No Analgesic Effect on CCI Induced Neuropathic Pain in Mice
por: Üçeyler, Nurcan, et al.
Publicado: (2010)